Celgene Corp Asset Turnover Ratio (CELG), as of third quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Celgene Corp  (NASDAQ: CELG)
 

Celgene Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Celgene's asset turnover ratio has remained unchanged compare to previous quarter at 0.44 in the third quarter (Sep 30 2019)

Within sector 90 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2019, to 1885, from total ranking in the second quarter 2019 at 2319.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELG Asset Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Asset Change 20.89 % 17.16 % 8.92 % 28.11 % 7.81 %
Y / Y Revenue Change 16.14 % 15.36 % 13.76 % 15.91 % 18.41 %
Asset Turnover Ratio (TTM) 0.44 0.44 0.45 0.44 0.45
CELG's Total Ranking # 1885 # 2319 # 2043 # 2319 # 1795
Seq. Asset Change 5.56 % 4.1 % 3.7 % 6.08 % 2.31 %
Seq. Revenue Change 2.73 % 9.32 % -0.3 % 3.73 % 2.05 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 91
Healthcare Sector # 215
Overall Market # 1885

Asset Turnover Ratio Statistics
High Average Low
27.57 7.86 5.61
(Dec. 31, 2005)   (March 31, 2012)




CELG Company Profile • Back to CELG Efficiency Comparisons • Compare CELG Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Assets at quarter ending Sep 30 2019
Phibro Animal Health Corporation  1.13 $ 817.562  Millions$ 725.002  Millions
Rennova Health Inc   1.13 $ 17.821  Millions$ 15.829  Millions
Ensign Group Inc  1.12 $ 2,263.147  Millions$ 2,020.347  Millions
Quorum Health Corporation  1.12 $ 1,763.505  Millions$ 1,577.859  Millions
Pro dex Inc   1.11 $ 27.496  Millions$ 24.760  Millions
Stereotaxis Inc   1.11 $ 29.278  Millions$ 26.380  Millions
Iridex Corp  1.10 $ 43.152  Millions$ 39.195  Millions
Biotricity Inc   1.10 $ 0.969  Millions$ 0.881  Millions
Genomic Health Inc  1.10 $ 441.873  Millions$ 403.434  Millions
Infusystem Holdings Inc  1.09 $ 76.968  Millions$ 70.394  Millions
Lexicon Pharmaceuticals Inc   1.08 $ 330.417  Millions$ 305.096  Millions
Invacare Holdings Corporation  1.07 $ 939.627  Millions$ 876.497  Millions
International Stem Cell Corporation  1.07 $ 8.858  Millions$ 8.315  Millions
Omeros Corporation  1.06 $ 100.405  Millions$ 94.551  Millions
Irhythm Holdings Inc   1.06 $ 198.373  Millions$ 187.532  Millions
Puma Biotechnology Inc   1.06 $ 280.417  Millions$ 265.595  Millions
Lakeland Industries Inc   1.06 $ 104.662  Millions$ 99.146  Millions
Kushco Holdings Inc   1.03 $ 148.954  Millions$ 144.886  Millions
Icagen, Inc.  1.02 $ 14.084  Millions$ 13.743  Millions
Ufp Technologies Inc   1.02 $ 198.818  Millions$ 194.391  Millions
Retractable Technologies Inc  1.02 $ 37.432  Millions$ 36.665  Millions
Lhc Group Inc   1.02 $ 2,058.768  Millions$ 2,017.573  Millions
Align Technology inc   1.02 $ 2,291.029  Millions$ 2,245.821  Millions
Alimera Sciences Inc  1.02 $ 51.709  Millions$ 50.847  Millions
Fibrocell Science, Inc.  1.02 $ 24.528  Millions$ 24.144  Millions
Aquestive Therapeutics Inc   1.01 $ 53.014  Millions$ 52.580  Millions
Lifeloc Technologies Inc   1.01 $ 8.715  Millions$ 8.668  Millions
Antares Pharma Inc   1.00 $ 104.846  Millions$ 104.801  Millions
Cardiff Lexington Corporation  0.99 $ 4.513  Millions$ 4.537  Millions
Catalyst Pharmaceuticals Inc   0.98 $ 72.684  Millions$ 74.113  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.